Personal information

No personal information available

Activities

Collapse all

Works (3)

Discovery and Characterization of a New Class of C5aR1 Antagonists Showing In Vivo Activity

Journal of Medicinal Chemistry
2024-03-14 | Journal article
DOI: 10.1021/acs.jmedchem.3c02375
Contributors: Francis Hubler; Dorte Renneberg; Hervé Siendt; Simon Stamm; Kurt Hilpert; Eva Caroff; Stephane Delahaye; Sylvie Froidevaux; Mark J. Murphy
Source: check_circle
Crossref

Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125

Journal of Medicinal Chemistry
2022-09-08 | Journal article
DOI: 10.1021/acs.jmedchem.2c00676
Contributors: Eva Caroff; Emmanuel A. Meyer; Päivi Äänismaa; Sylvie Froidevaux; Marcel Keller; Luca Piali
Source: check_circle
Crossref

Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases

Journal of Medicinal Chemistry
2022-09-08 | Journal article
DOI: 10.1021/acs.jmedchem.2c00675
Contributors: Emmanuel A. Meyer; Päivi Äänismaa; Sylvie Froidevaux; Marcel Keller; Luca Piali; Eva Caroff
Source: check_circle
Crossref

Peer review (4 reviews for 2 publications/grants)

Review activity for ACS medicinal chemistry letters. (1)
Review activity for Journal of medicinal chemistry. (3)
How many people are using ORCID?